News related to Revlimid (Lenalidomide) and/or conditions it is approved for
Multiple myeloma patients vulnerable to 'financial toxicity,' due to costly treatments
Source: Health Insurance / Medical Insurance News From Medical News Today [2015.09.17]
Even patients with health insurance who have multiple myeloma may be vulnerable to "financial toxicity" - including those who make over $100,000 a year - because of the higher use of novel...
Penn team: Sustained remission of multiple myeloma after personalized cellular therapy
Source: Transplants / Organ Donations News From Medical News Today [2015.09.10]
New treatment combination with CTL019 targets precursors of cancerous white blood cellsA multiple myeloma patient whose cancer had stopped responding after nine different treatment regimens...
Source: MedicineNet thalidomide Specialty [2015.04.30]
Title: Multiple Myeloma
Category: Symptoms and Signs
Created: 4/30/2015 12:00:00 AM
Last Editorial Review: 4/30/2015 12:00:00 AM
Babies after Breast Cancer: Cancer Network and OncoTherapy Network
Source: MedPage Today OB/Gyn [2015.09.29]
(MedPage Today) -- Also, the high price of multiple myeloma therapy